Essential (hemorrhagic) thrombocythemia digital illustration

Essential (hemorrhagic) thrombocythemia Save

ICD-10 code: D47.3

Chapter: Neoplasms

Essential (Hemorrhagic) Thrombocythemia: Symptoms, Causes, and Treatment

Essential thrombocythemia (ET) is a rare blood disorder that affects the production of platelets in the bone marrow. Platelets are responsible for blood clotting, and individuals with ET have an excessive amount of platelets in their blood. This can lead to complications such as blood clots, bleeding, and even stroke.

Here are some of the common symptoms of ET:

  1. Headaches
  2. Fatigue
  3. Dizziness
  4. Blurred vision
  5. Bleeding gums
  6. Bruising easily

The exact cause of ET is unknown, but it is believed to be related to genetic mutations. It can also occur as a secondary condition to other blood disorders or cancers. ET is typically diagnosed through blood tests to measure platelet counts and bone marrow biopsies to examine the bone marrow for abnormalities.

Treatment for ET depends on the severity of the condition and the risk of complications. For individuals with mild symptoms, regular monitoring and lifestyle changes such as quitting smoking and avoiding certain medications may be recommended. For those with more severe symptoms, medications such as aspirin or blood thinners may be prescribed. In some cases, chemotherapy or other treatments to reduce platelet production may be necessary.

It is important for individuals with ET to work closely with a hematologist or other medical professional to manage their condition and prevent complications. In addition to medical treatment, maintaining a healthy lifestyle and avoiding activities that increase the risk of bleeding or blood clots can also help manage this condition.

If you are experiencing any of the symptoms of ET or have been diagnosed with this condition, it is important to seek medical attention and work with your healthcare provider to develop a treatment plan that is right for you.

Diagnosis Codes for Essential (hemorrhagic) thrombocythemia | D47.3